PGAP4
GPI-N-acetylgalactosamine transferase PGAP4
Also known as: C9orf125, MGC12992, PGAP4_HUMAN, TMEM246
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRR3
- Gene
- PGAP4
- Ensembl
- ENSG00000165152
- Chromosome
- 9
- Canonical length
- 403 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles
OverviewNCBI Gene
Enables glycosyltransferase activity. Involved in GPI anchor biosynthetic process. Located in Golgi membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
403 residues, UniProt reviewed canonical sequence.
>Q9BRR3|PGAP4
1 MSTSTSPAAM LLRRLRRLSW GSTAVQLFIL TVVTFGLLAP LACHRLLHSY FYLRHWHLNQ
61 MSQEFLQQSL KEGEAALHYF EELPSANGSV PIVWQATPRP WLVITIITVD RQPGFHYVLQ
121 VVSQFHRLLQ QCGPQCEGHQ LFLCNVERSV SHFDAKLLSK YVPVANRYEG TEDDYGDDPS
181 TNSFEKEKQD YVYCLESSLQ TYNPDYVLMV EDDAVPEEQI FPVLEHLLRA RFSEPHLRDA
241 LYLKLYHPER LQHYINPEPM RILEWVGVGM LLGPLLTWIY MRFASRPGFS WPVMLFFSLY
301 SMGLVELVGR HYFLELRRLS PSLYSVVPAS QCCTPAMLFP APAARRTLTY LSQVYCHKGF
361 GKDMALYSLL RAKGERAYVV EPNLVKHIGL FSSLRYNFHP SLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PGAP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 29 nTPM
- cerebellum: 28 nTPM
- cerebral cortex: 27 nTPM
- hypothalamus: 24 nTPM
- hippocampal formation: 17 nTPM
- cervix: 16 nTPM
Single-cell type
- esophageal apical cells: 61 nCPM
- tuft cells: 58 nCPM
- esophageal suprabasal cells: 51 nCPM
- foveolar cells: 48 nCPM
- other brain neurons: 47 nCPM
- corticotrophs: 45 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 67 nTPM
- hypothalamus: 67 nTPM
- cerebral cortex: 66 nTPM
- basal ganglia: 56 nTPM
- hippocampal formation: 54 nTPM
- white matter: 53 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.09
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPI-GalNAc transferase PGAP4
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PGAP4 as an antibody target. Whether an autoantibody or antibody against PGAP4 could matter depends on whether native PGAP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PGAP4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PGAP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...